Alnylam Pharmaceuticals News

Latest Alnylam Pharmaceuticals news, funding rounds and robotics & AI coverage. 1 article tracked by The Robotics Media.

About Alnylam Pharmaceuticals

American biopharmaceutical company that pioneered RNA interference (RNAi) therapeutics, developing and commercialising siRNA drugs across rare genetic, cardiometabolic, infectious and CNS diseases.

Key facts

Country: United States
Founded: 2002
Sectors: Digital Health

Latest Alnylam Pharmaceuticals news

Alnylam Pays Inceptive $30M Upfront In Up-To-$2B AI siRNA Deal — Alnylam is staking $30M upfront and up to $2B in milestones on Transformer co-author Jakob Uszkoreit's Inceptive Nucleics to redesign siRNA therapeuti...